Filter
1461
Text search:
dosage
Featured
197
424
Language
Document type
844
298
150
63
44
21
16
8
7
4
4
1
1
Countries
108
45
44
39
38
29
28
26
26
25
20
20
19
19
18
18
17
16
15
15
13
13
13
12
12
12
10
10
8
8
8
8
7
7
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
607
228
95
71
27
22
18
1
1
Toolboxes
127
113
99
91
74
65
44
39
36
33
22
15
13
13
10
9
8
6
5
5
5
2
Accessed November, 2017
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
WHO/CDS/CSR/EDC/99.2 Plague Manual
Epidemiology, Distribution, Surveillance and Control
PMPB/INS-GUIDE/02
Therapeutics Information and Pharmacovigilance Centre | TIPC
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
